Warfarin: Any harm in long-term use?

  • image.alt
  • With Mayo Clinic cardiologist

    Martha Grogan, M.D.

    read biography
The Mayo Clinic Diet Book, learn more

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Question

Warfarin: Any harm in long-term use?

Is there any harm in taking long-term, low-dose warfarin for an extended period after an episode of deep vein thrombosis?

Answer

from Martha Grogan, M.D.

Warfarin (Coumadin) is a blood-thinning medication (anticoagulant) used to treat and prevent blood clots. For most people with a single episode of deep vein thrombosis (DVT), treatment with full-dose blood thinners is usually for only a limited time. Taking warfarin at a high dose for a longer period of time is only recommended for people who are at a high risk of developing blood clots that could cause a heart attack, stroke or pulmonary embolism.

Long-term, low-dose treatment with warfarin may prevent future episodes of DVT, but it's not without risk. There's a risk of serious or even fatal bleeding — especially when warfarin is taken in high doses or for long periods of time.

Ask your doctor to help you weigh the benefits and risks of long-term, low-dose warfarin therapy in your case. Also consider these self-care measures to prevent future episodes of DVT:

  • Avoid sitting, squatting or crossing your legs for long periods of time.
  • If you must sit for long periods, such as during a plane or car trip, take a short walk every hour or two. It also helps to flex your ankles, curl your toes and tap your feet frequently.
  • Drink plenty of fluids to prevent dehydration.
  • Wear support hosiery or compression stockings, available at medical supply stores.

If you're taking warfarin to prevent blood clots that could cause a heart attack or stroke, make sure you take it exactly as prescribed. Warfarin is a powerful medication that can have dangerous side effects.

References
  1. Kearon C. Balancing risks and benefits of extended anticoagulant therapy for idiopathic venous thrombosis. Journal of Thrombosis and Haemostasis. 2009;7:296.
  2. Kearon C, et al. Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: Results from a randomized trial. Blood. 2008;112:4432.
  3. Rodger M, et al. Unprovoked venous thromboembolism: Short-term or indefinite anticoagulation? Balancing long-term risk and benefit. Blood Reviews. 2010;24:171.
HQ01614 March 17, 2011

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger